Who are Collagenase Clostridium Histolyticum-Aaes's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Qwo, Control - Crossover to CCH, XIAFLEX, Injectable clostridial collagenase, CCH administration.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/collagenase-clostridium-histolyticum-aaes.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Collagenase Clostridium Histolyticum-Aaes — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Collagenase Clostridium Histolyticum-Aaes (Collagenase Clostridium Histolyticum-Aaes) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Collagenase enzyme. Area: Dermatology / Rheumatology.

marketed Collagenase enzyme Collagen types I and III Dermatology / Rheumatology Small molecule Live · refreshed every 30 min

Target snapshot

Collagenase Clostridium Histolyticum-Aaes (Collagenase Clostridium Histolyticum-Aaes) — Luxurgery. Collagenase Clostridium Histolyticum-Aaes is a bacterial enzyme that directly breaks down collagen in connective tissue, allowing mechanical disruption of fibrotic structures.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Collagenase Clostridium Histolyticum-Aaes TARGET	Collagenase Clostridium Histolyticum-Aaes	Luxurgery	marketed	Collagenase enzyme	Collagen types I and III
Qwo	Qwo	DMR Research, PLLC	marketed	Collagenase enzyme	Collagen types I and III
Control - Crossover to CCH	Control - Crossover to CCH	Charitable Union for the Research and Education of Peyronie's Disease	marketed	Collagenase enzyme	Collagen (types I and III)
XIAFLEX	XIAFLEX	Hospital for Special Surgery, New York	marketed	Collagenase enzyme	Collagen (types I, II, III, IV, V, VI, VII)
Injectable clostridial collagenase	Injectable clostridial collagenase	Indiana Hand to Shoulder Center	marketed	Collagenase enzyme	Collagen (types I and III)
CCH administration	CCH administration	Charitable Union for the Research and Education of Peyronie's Disease	marketed	Collagenase enzyme	Collagen I and III

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Collagenase enzyme class)

Charitable Union for the Research and Education of Peyronie's Disease · 2 drugs in this class
DMR Research, PLLC · 1 drug in this class
Hospital for Special Surgery, New York · 1 drug in this class
Indiana Hand to Shoulder Center · 1 drug in this class
Luxurgery · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Collagenase Clostridium Histolyticum-Aaes — Competitive Intelligence Brief. https://druglandscape.com/ci/collagenase-clostridium-histolyticum-aaes. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab